← Back to Clinical Trials
Recruiting NCT07551141

NCT07551141 Effects of Plantar Vibration on Gait and Balance in Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07551141
Status Recruiting
Phase —
Sponsor Bitlis Eren University
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 34 participants
Start Date 2026-07-24
Primary Completion 2026-11

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Plantar VibrationPlacebo Plantar Vibration

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 34 participants in total. It began in 2026-07-24 with a primary completion date of 2026-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the effects of local vibration applied to the plantar surface of the foot on gait speed and dynamic balance in individuals with stroke.

Eligibility Criteria

Inclusion Criteria: * Stroke occurred at least 6 months prior to enrollment. * No cognitive or communication impairments that would interfere with participation. * Ability to stand independently for 20 seconds or more. * Ability to walk 10 meters independently, with or without walking aids or orthoses as needed. * Age between 18 and 75 years. * Lower extremity Brunnstrom stage of 4 or higher. Exclusion Criteria: * Presence of severe osteoarthritis in the lower extremities. * Diagnosis of cancer or diabetic neuropathy. * Presence of vestibular disorders. * Lower extremity ulceration or amputation. * History of vertigo. * Alcohol consumption within the past 24 hours. * Hemodynamic instability. * Stroke affecting the basilar artery or cerebellum (posterior circulation stroke). * Presence of neurological disorders such as multiple sclerosis or Parkinson's disease. * Acute lower extremity injury within the past 6 weeks. * History of lower extremity surgery.

Contact & Investigator

Central Contact

Merve TUNÇDEMİR DURSUN, Asst. Prof.

✉ merve.kd@hotmail.com

📞 5069452008

Principal Investigator

Merve TUNÇDEMİR DURSUN, Asst. Prof.

PRINCIPAL INVESTIGATOR

Bitlis Eren University

Frequently Asked Questions

Who can join the NCT07551141 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07551141 currently recruiting?

Yes, NCT07551141 is actively recruiting participants. Contact the research team at merve.kd@hotmail.com for enrollment information.

Where is the NCT07551141 trial being conducted?

This trial is being conducted at Bolu, Turkey (Türkiye).

Who is sponsoring the NCT07551141 clinical trial?

NCT07551141 is sponsored by Bitlis Eren University. The principal investigator is Merve TUNÇDEMİR DURSUN, Asst. Prof. at Bitlis Eren University. The trial plans to enroll 34 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology